This provides a clear example of the context dependence of IGFBP5, with one study suggesting that increased IGFBP5 in serum is correlated with NAFLD progression and severity, while another suggests the opposite based on expression in diseased liver tissue. The gene discussed is IGFBP5; the disease is metabolic dysfunction-associated steatotic liver disease.